International Journal of Endocrinology and Metabolism
Research Institute for Endocrine Sciences
Scopus by Title (Ref)
1. Lowering the dexamethasone suppression test cut-off: is it time yet?
- Favero V. , et al.
2. Increased arterial stiffness and atherosclerosis in patients with nonfunctioning adrenal incidentaloma
- Parasiliti-Caprino M. , et al.
3. Comparative analysis of cardiac dysfunction in non-functioning adrenal adenomas, primary aldosteronism, and essential hypertension
- Liu L. , et al.
4. Cardiometabolic comorbidities and cardiovascular events in “non-functioning” adrenal incidentalomas: a systematic review and meta-analysis
- Favero V. , et al.
5. Increased cardiometabolic risk and prevalence of ascending aorta dilation in patients with nonfunctioning adrenal incidentaloma: a retrospective propensity score-matched study
- Parasiliti-Caprino M. , et al.
6. Clinical, radiological, and surgical outcomes of 431 patients with adrenal incidentalomas: retrospective study of a 10-year single-center experience
- Nasiroğlu İmga N. , et al.
7. Do Non-Functional Adrenal Adenomas Affect Metabolic Profile and Carotid Intima-Media Thickness? A Single Centre Study from Poland
- Szychlińska M. , et al.
8. Possible, probable, and certain hypercortisolism: A continuum in the risk of comorbidity
- Araujo-Castro M. , et al.
9. Could a nonfunctional adrenal incidentaloma be a risk factor for increased carotid intima-media thickness and 10-year cardiovascular mortality based on the SCORE algorithm? A study from a single centre in Poland
- Szychlińska M. , et al.
10. A retrospective study on the association between urine metanephrines and cardiometabolic risk in patients with nonfunctioning adrenal incidentaloma
- Parasiliti-Caprino M. , et al.
11. NEW BIOMARKERS TO PREDICT CARDIOVASCULAR RISK IN PATIENTS WITH ADRENAL INCIDENTALOMA; IRISIN AND NESFATIN-1
- Can M. , et al.
12. Assessment of subclinical cardiovascular alterations in nonfunctioning adrenal incidentalomas
- Can B. , et al.
13. Cardiovascular and metabolic risk factors in patients with subclinical Cushing
- Petramala L. , et al.
14. Markers of subclinical cardiovascular disease in patients with adrenal incidentaloma
- Szychlińska M. , et al.
15. Could a nonfunctional adrenal incidentaloma be a risk factor for increased carotid intima-media thickness and metabolic syndrome
- Emral R. , et al.
16. Adrenal Incidentaloma: Picking out the High-Risk Patients
- Di Dalmazi G. , et al.
17. Serum Amyloid A, Paraoxonase-1 Activity, and Apolipoprotein Concentrations as Biomarkers of Subclinical Atherosclerosis Risk in Adrenal Incidentaloma Patients
- Imga N. , et al.
18. Update on the risks of benign adrenocortical incidentalomas
- Di Dalmazi G. , et al.